Science Journals Under Fire; Infusion System Recall; Visual Impairment and Suicide

— Health news and commentary from around the Web gathered by MedPage Today staff

MedpageToday
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Note that some links may require registration or subscription.

House Republicans claimed during a public hearing that government scientists influenced scientific journals when it came to publishing COVID origin research. (Nature)

In a nationwide first, a new Colorado law was passed to protect individuals' biological data including neural data generated by the brain. (New York Times)

Italy passed measures that will allow anti-abortion activists to enter abortion clinics. (Washington Post)

Almost all doses of Eli Lilly's diabetes and obesity injectable tirzepatide (Mounjaro, Zepbound) will be in short supply through the second quarter of this year, the FDA website noted. (Reuters)

How should the supply of diabetes and obesity drugs be allocated? Experts weighed in. (New England Journal of Medicine)

The continued shortage of the growth hormone somatropin (Norditropin) since fall 2022 is still affecting patients with hormone deficiencies like Prader-Willi syndrome. (NPR)

The World Health Organization and 500 experts agreed for the first time what it means for a disease to spread through the air. (Reuters)

The FDA announced a Class I recall of Fresenius Kabi USA's Ivenix Infusion System used for the controlled administration of fluids due to software anomalies that could result in death.

Arizona House Democrats were blocked repeatedly when they tried to repeal an 1864 ban on abortion that's slated to become state law again. (Reuters)

Two in five people with atrial fibrillation will likely develop heart failure over their remaining lifetime while one in five will have a stroke, a Danish study showed. (BMJ)

There's evidence of racial and ethnic healthcare disparities in every state, a Commonwealth Fund report detailed.

Although three major asthma inhaler makers pledged to cap out-of-pocket costs for some patients at $35, this doesn't apply to daily inhalers used by the youngest kids with asthma. (CNN)

Visual impairment was linked with an increased risk of suicidal ideation, suicidal behavior, and suicide death in a meta-analysis. (JAMA Network Open)

The Justice Department agreed to pay the survivors of former USA Gymnastics team doctor Larry Nassar's abuse over $100 million for the FBI's mishandling of the case. (USA Today)

A ZoomRx survey found 65% of the top 20 pharma companies ban or restrict the use of ChatGPT by their employees. (Endpoints News)

Actress Olivia Munn revealed she underwent four surgeries, a double mastectomy, and medically-induced menopause to fight breast cancer. (People)

Women with surprise pregnancies after taking GLP-1 receptor agonists for weight loss are now dealing with fallout of quitting the injectables cold-turkey. (USA Today)

States are trying to pass laws to prevent private-equity healthcare takeovers. (Wall Street Journal)

Since Brexit, drug shortages in the U.K. more than doubled from 2020 to 2023. (Reuters)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.